Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Cielo

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Cielo head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 172 · Grade C

Cielo

Visit Cielo Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 69 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Cielo a bad call — it's best for readers comparing advertised monthly plans with longer commitments who can obtain a complete patient agreement first. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
72
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
80
Track Record
88
68
CoreAge RxBrief Score 94 · 69Cielo

Price, coverage & the tracker

CoreAge RxCielo
Brief Score94/100 (A)69/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm promotional terms

Flash-sale $139/mo versus displayed regular $199; actual renewal charge unconfirmed. The $84 equivalent requires 12 months with full payment unconfirmed.

Full price details

Compounded semaglutide offered; complete current renewal quote unknown; flash-sale monthly offer $139 versus displayed regular $199; $84 equivalent requires 12 months with full charge unconfirmed; earlier listing: From $149/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm promotional terms

Flash-sale $189/mo versus displayed regular $299; actual renewal charge unconfirmed. The $119 equivalent requires 12 months with full payment unconfirmed.

Full price details

Compounded tirzepatide offered; complete current renewal quote unknown; flash-sale monthly offer $189 versus displayed regular $299; $119 equivalent requires 12 months with full charge unconfirmed; earlier listing: From $249/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeConfirm medication-specific clinician and pharmacy access; a complete current state roster was not established
Brand-name accessNot confirmedCurrent branded-medication program unconfirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Cielo: Flash-sale monthly offers show $139 semaglutide/$189 tirzepatide; renewal prices and full longer-plan charges remain unconfirmed.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.